Show simple item record

dc.contributor.authorLiu, Dawei
dc.contributor.authorSzili, Endre J
dc.contributor.authorOstrikov, Kostya Ken
dc.date.accessioned2020-10-20T02:13:28Z
dc.date.available2020-10-20T02:13:28Z
dc.date.issued2020
dc.identifier.issn1612-8850en_US
dc.identifier.doi10.1002/ppap.202000097en_US
dc.identifier.urihttp://hdl.handle.net/10072/398494
dc.description.abstractAdvances in digital technologies have opened new opportunities for creating more reliable, time‐ and cost‐effective, safer and mobile methods of diagnosing, managing and treating diseases. A few examples of advanced nano‐ and digital technologies are already FDA‐approved for diagnosing and treating diseases. Plasma treatment is still emerging as a new healthcare technology, but it is showing a strong potential for treatment of many diseases including cancers and antimicrobial‐resistant infections, with little or no adverse side effects. Here, we argue that with the ever‐increasing complex healthcare challenges facing communities, including the ongoing COVID‐19 pandemic, it is critical to consider combining unique properties of emerging healthcare technologies into a single multimodal treatment modality that could lead to unprecedented healthcare benefits. In this article, we focus on the healthcare opportunities created by establishing a nexus between plasma, nano‐ and digital technologies. We argue that the combination of plasma, nano‐ and digital technologies into a single multimodal healthcare package may significantly improve patient outcomes and comfort, and reduce the economic burden on community healthcare, as well as alleviate many problems related to overcrowded healthcare systems.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.language.isoeng
dc.publisherWileyen_US
dc.relation.ispartofpagefrom2000097en_US
dc.relation.ispartofissue10en_US
dc.relation.ispartofjournalPlasma Processes and Polymersen_US
dc.relation.ispartofvolume17en_US
dc.subject.fieldofresearchAtomic, Molecular, Nuclear, Particle and Plasma Physicsen_US
dc.subject.fieldofresearchPhysical Chemistry (incl. Structural)en_US
dc.subject.fieldofresearchMaterials Engineeringen_US
dc.subject.fieldofresearchcode0202en_US
dc.subject.fieldofresearchcode0306en_US
dc.subject.fieldofresearchcode0912en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsPhysical Sciencesen_US
dc.subject.keywordsPhysics, Applieden_US
dc.subject.keywordsPhysics, Fluids & Plasmasen_US
dc.subject.keywordsPhysics, Condensed Matteren_US
dc.titlePlasma medicine: Opportunities for nanotechnology in a digital ageen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationLiu, D; Szili, EJ; Ostrikov, KK, Plasma medicine: Opportunities for nanotechnology in a digital age, PLASMA PROCESSES AND POLYMERS, 2020, pp. 2000097en_US
dcterms.dateAccepted2020-06-28
dc.date.updated2020-10-20T02:11:42Z
gro.hasfulltextNo Full Text
gro.griffith.authorOstrikov, Kostya (Ken)


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record